Dynamic Technology Lab’s Supernus Pharmaceuticals SUPN Stock Holding History

Dynamic Technology Lab’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+6,402	New	+$307K	0.07%	450
2025 Q3	–	Sell	-6,810	Closed	-$215K	–	1196
2025 Q2	$215K	Buy	+6,810	New	+$218K	0.03%	780
2024 Q4	–	Sell	-11,288	Closed	-$352K	–	1336
2024 Q3	$352K	Buy	+11,288	New	+$352K	0.04%	676
2023 Q3	–	Sell	-12,974	Closed	-$390K	–	1312
2023 Q2	$390K	Sell	12,974 -3,856	-23%	-$135K	0.05%	601
2023 Q1	$610K	Sell	16,830 -1,881	-10%	-$72.3K	0.06%	557
2022 Q4	$667K	Buy	+18,711	New	+$650K	0.07%	484
2022 Q1	–	Sell	-25,382	Closed	-$740K	–	1494
2021 Q4	$740K	Buy	+25,382	New	+$770K	0.08%	418
2021 Q2	–	Sell	-8,309	Closed	-$218K	–	1514
2021 Q1	$218K	Buy	+8,309	New	+$232K	0.02%	918
2019 Q1	–	Sell	-7,626	Closed	-$254K	–	1325
2018 Q4	$254K	Buy	+7,626	New	+$328K	0.04%	716
2018 Q1	–	Sell	-18,704	Closed	-$746K	–	1351
2017 Q4	$746K	Buy	+18,704	New	+$739K	0.13%	250
2015 Q1	–	Sell	-16,178	Closed	-$134K	–	864
2014 Q4	$134K	Buy	+16,178	New	+$136K	0.07%	546
2014 Q2	–	Sell	-10,209	Closed	-$91K	–	819
2014 Q1	$91K	Buy	+10,209	New	+$94K	0.05%	527

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Dynamic Technology Lab's SUPN Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 6,402 shares worth $298K. The stake represents 0.07% of the portfolio and ranks #450 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in SUPN as recently as Q2 2025.

Dynamic Technology Lab first reported a position in SUPN in Q1 2014 and has held it in 12 quarters since. The position peaked at $746K in Q4 2017. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Dynamic Technology Lab held 6,402 shares of Supernus Pharmaceuticals worth $298K as of Q2 2026.
Supernus Pharmaceuticals was a new Dynamic Technology Lab position in Q2 2026.
Supernus Pharmaceuticals made up 0.07% of Dynamic Technology Lab's portfolio in Q2 2026, its #450 holding.
Dynamic Technology Lab first reported a position in Supernus Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
Dynamic Technology Lab's Supernus Pharmaceuticals position peaked at $746K in Q4 2017.
335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.